$9.04
0.78%
Nasdaq, Aug 29, 10:00 pm CET
ISIN
US50015M1099
Symbol
KOD

Kodiak Sciences, Inc. Stock price

$9.04
+1.24 15.90% 1M
+4.93 119.95% 6M
-0.91 9.15% YTD
+6.56 264.52% 1Y
-1.80 16.61% 3Y
-43.55 82.81% 5Y
-1.12 11.02% 10Y
-1.12 11.02% 20Y
Nasdaq, Closing price Fri, Aug 29 2025
+0.07 0.78%
ISIN
US50015M1099
Symbol
KOD
Industry

Key metrics

Basic
Market capitalization
$477.5m
Enterprise Value
$373.3m
Net debt
positive
Cash
$104.2m
Shares outstanding
52.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
6.8
Financial Health
Equity Ratio
44.8%
Return on Equity
-117.3%
ROCE
-91.9%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-176.8m | $-229.3m
EBIT
$-207.4m | $-238.2m
Net Income
$-199.8m | $-220.3m
Free Cash Flow
$-115.7m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
8.3% | -43.2%
EBIT
2.1% | -27.5%
Net Income
-1.1% | -25.0%
Free Cash Flow
27.2%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-3.8
FCF per Share
$-2.2
Short interest
8.6%
Employees
121
Rev per Employee
$0.0
Show more

Is Kodiak Sciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Kodiak Sciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Kodiak Sciences, Inc. forecast:

2x Buy
15%
3x Hold
23%
8x Sell
62%

Analyst Opinions

13 Analysts have issued a Kodiak Sciences, Inc. forecast:

Buy
15%
Hold
23%
Sell
62%

Financial data from Kodiak Sciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 55 55
17% 17%
-
- Research and Development Expense 150 150
3% 3%
-
-177 -177
8% 8%
-
- Depreciation and Amortization 31 31
60% 60%
-
EBIT (Operating Income) EBIT -207 -207
2% 2%
-
Net Profit -200 -200
1% 1%
-

In millions USD.

Don't miss a Thing! We will send you all news about Kodiak Sciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kodiak Sciences, Inc. Stock News

Neutral
PRNewsWire
5 days ago
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , Aug. 27, 2025 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced its interim results for the six months ended June 30, 2025.
Neutral
PRNewsWire
13 days ago
PALO ALTO, Calif. , Aug. 19, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that senior management will present the Company's pipeline programs in glaucoma at the American Chemical Society (ACS) Fall 2025 Meeting on Tuesday, August ...
Neutral
PRNewsWire
19 days ago
PALO ALTO, Calif. , Aug. 13, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the second quarter ended June 30, 2025.
More Kodiak Sciences, Inc. News

Company Profile

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline includes KSI-301 for wet AMD; KSI-301 for diabetic eye disease; KSI-501 for DME and uveitis; KSI-201 for resistant wet AMD; and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Head office United States
CEO Victor Perlroth
Employees 121
Founded 2009
Website kodiak.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today